The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Successful Treatment of Eosinophilic Gastroenteritis with Clarithromycin

  • Ohe, Masashi (Department of General Medicine, Hokkaido Social Insurance Hospital) ;
  • Hashino, Satoshi (Department of Gastroenterology and Hematology, Hokkaido University Graduate School of Medicine)
  • Published : 2012.12.01
⟨ Previous Next ⟩

Abstract

Eosinophilic gastroenteritis (EGE) is an uncommon disease characterized by eosinophilic infiltration of the gastrointestinal tract, which is usually associated with abdominal pain, diarrhea, ascites, and peripheral eosinophilia. Steroids remain the mainstay of treatment for EGE, but symptoms often recur when the dose is reduced. Macrolides have immunomodulatory effects as well as antibacterial effects. The immunomodulatory effect results in inhibition of T-lymphocyte proliferation and triggering of T-lymphocyte and eosinophil apoptosis. Macrolides also have a steroidsparing effect through their influence on steroid metabolism. We report a rare case of EGE, which relapsed on steroid reduction but improved following clarithromycin treatment.

Keywords

References

  1. Ishimatsu Y, Kadota J, Iwashita T, et al. Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro. Int J Antimicrob Agents 2004;24:247-253. https://doi.org/10.1016/j.ijantimicag.2004.03.022
  2. Wu L, Zhang W, Tian L, Bao K, Li P, Lin J. Immunomodulatory effects of erythromycin and its derivatives on human T-lymphocyte in vitro. Immunopharmacol Immunotoxicol 2007;29:587-596. https://doi.org/10.1080/08923970701692841
  3. Adachi T, Motojima S, Hirata A, et al. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol 1996;98(6 Pt 2):S207-S215. https://doi.org/10.1016/S0091-6749(96)70068-4
  4. Amayasu H, Yoshida S, Ebana S, et al. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000;84:594-598. https://doi.org/10.1016/S1081-1206(10)62409-X
  5. Justinich C, Katz A, Gurbindo C, et al. Elemental diet improves steroid-dependent eosinophilic gastroenteritis and reverses growth failure. J Pediatr Gastroenterol Nutr 1996;23:81-85. https://doi.org/10.1097/00005176-199607000-00014
  6. Verheijden NA, Ennecker-Jans SA. A rare cause of abdominal pain: eosinophilic gastroenteritis. Neth J Med 2010;68:367-369.
  7. Sheikh RA, Prindiville TP, Pecha RE, Ruebner BH. Unusual presentations of eosinophilic gastroenteritis: case series and review of literature. World J Gastroenterol 2009;15:2156-2161. https://doi.org/10.3748/wjg.15.2156
  8. Quack I, Sellin L, Buchner NJ, Theegarten D, Rump LC, Henning BF. Eosinophilic gastroenteritis in a young girl: long term remission under Montelukast. BMC Gastroenterol 2005;5:24. https://doi.org/10.1186/1471-230X-5-24
  9. Shirai T, Hashimoto D, Suzuki K, et al. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate. J Allergy Clin Immunol 2001;107:924-925. https://doi.org/10.1067/mai.2001.114705
  10. Garrett JK, Jameson SC, Thomson B, et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004;113:115-119. https://doi.org/10.1016/j.jaci.2003.10.049

Cited by

  1. The management of eosinophilic gastroenteritis vol.50, pp.11, 2012, https://doi.org/10.3109/00365521.2015.1049655
  2. Eosinophilic gastroenteritis: Approach to diagnosis and management vol.7, pp.4, 2012, https://doi.org/10.4292/wjgpt.v7.i4.513
  3. Pharmacological treatment of eosinophilic gastrointestinal disorders vol.9, pp.9, 2012, https://doi.org/10.1080/17512433.2016.1190268
  4. Successful additional clarithromycin and tacrolimus treatment for hypereosinophilia associated with eosinophilic granulomatosis with polyangiitis vol.26, pp.2, 2012, https://doi.org/10.12793/tcp.2018.26.2.60
  5. Causes of eosinophilic ascites - A systematic review vol.57, pp.2, 2019, https://doi.org/10.2478/rjim-2018-0041